BigPharma

Trump Urged to Take Strong Stance Against Big Pharma by Icelandic Drug Manufacturer

5 days ago

A prominent Icelandic drugmaker has issued a call for former President Donald Trump to adopt a more aggressive approach towards the pharmaceutical industry. This appeal follows Trump's criticism of soaring drug prices during his tenure in office and reflects ongoing concerns over affordability and access to essential medications.

Merck's $8 Billion Cancer Vaccine Faces Pivotal First US Jury Trial

2 months ago

In a landmark development for the biotechnology industry, Merck & Co.'s groundbreaking cancer vaccine is set to undergo its first jury trial in the United States. This legal battle comes at a critical time as Merck seeks to reinforce its position in the competitive pharmaceutical market, highlighting the substantial financial stakes involved—amounting to a staggering $8 billion.

Insights from Sandoz CEO Richard Saynor on Ozempic, Big Pharma Struggles, and Political Influences

3 months ago

In a candid conversation, Richard Saynor, CEO of Sandoz, provided a deep dive into the complexities surrounding the pharmaceutical landscape, including the rising prominence of Ozempic, challenges facing the industry, and the influence of political figures such as Donald Trump. Saynor’s insights shed light on the evolving narratives within Big Pharma and the implications for patients, healthcare, and future drug development.

Activist Investor Starboard Value Makes a Bold Move with a $1 Billion Stake in Pharmaceutical Giant Pfizer

6 months ago

In a significant financial maneuver, Starboard Value LP, a prominent activist investment firm, has acquired a substantial $1 billion stake in the global pharmaceutical behemoth Pfizer Inc. This strategic investment marks an assertive push by Starboard into the healthcare sector, aiming to influence the company's direction and potentially unlock shareholder value.